Christopher Silber - Concepedia

Author

Christopher Silber

Also Known As

C Silber, C. J. Silber, C. Silber, Christopher J. Silber, Christopher Silber

Publications

975

Citations

H-Index

Concepts

All Affiliations

Christopher Silber is an author at Sage Therapeutics (United States) specializing in neurology, medicine, and geriatrics.

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	32
2	Geriatrics	1	1	32
3	Neurology	1	1	32
4	Pharmacology	1	1	32
5	Alzheimer's Disease	1	1	32

Christopher Silber

Publications

883

Citations

H-Index

Page 1

	Year	Citations
Migraine Prophylaxis With Divalproex N. T. Mathew, Joel R. Saper, Stephen D. Silberstein, Archives of Neurology	1995	324
Effect of Zuranolone vs Placebo in Postpartum Depression Kristina M. Deligiannidis, Samantha Meltzer‐Brody, Handan Gunduz‐Bruce, JAMA Psychiatry	2021	236
Trial of SAGE-217 in Patients with Major Depressive Disorder Handan Gunduz-Bruce, Christopher Silber, Inder Kaul, New England Journal of Medicine	2019	224
Prevention protocols for Alzheimer disease. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. L. J. Thal, Angelico Carta, Rachelle S. Doody, PubMed Neurodegenerative DiseasesAlzheimer's DiseasePreventive MedicineGeriatricsDementia	1997	32
Zuranolone as an oral adjunct to treatment of Parkinsonian tremor: A phase 2, open-label study Amy Bullock, Inder Kaul, Sigui Li, Journal of the Neurological Sciences	2020	27
Patient-reported health-related quality of life from a randomized, placebo-controlled phase 2 trial of zuranolone in adults with major depressive disorder Ellison Suthoff, Mark Kosinski, Alix Arnaud, Journal of Affective Disorders	2022	22
A phase 1 double‐blind, placebo‐controlled study of zuranolone (SAGE‐217) in a phase advance model of insomnia in healthy adults Amy Bullock, Handan Gunduz‐Bruce, Gary Zammit, Human Psychopharmacology Clinical and Experimental	2021	18

Page 1